Product Information
AMLODIPINE-VALSARTAN 5-160 MG is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3721 per EA under NDC 65862073730. Its NADAC has been published 507 times since Oct 12, 2016.
Strength
5; 160 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862073730
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BESYLATE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA206512On Market Since
4/22/2016
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN 5-160 MG has been published 507 times since Oct 12, 2016, and over the history we have for it it has declined 30.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3721 per EA |
|---|---|
| All-time high | $0.5411 (Jan 11, 2017) |
| All-time low | $0.3449 (Jul 17, 2024) |
| 52-week high | $0.4954 |
| 52-week low | $0.3721 |
| Median price | $0.4545 |
| Average price | $0.4520 |
| Largest weekly change | +35.2% (Aug 21, 2024) |
| Weeks tracked | 507 |
| Tracking since | Oct 12, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Amlodipine and valsartan market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN 5-160 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 5-160 MG, manufactured by Aurobindo Pharma Limited, is $0.3721 per EA (NDC 65862073730), effective Jun 24, 2026.
How has the price of AMLODIPINE-VALSARTAN 5-160 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has declined 30.2%. It has been tracked across 507 weekly CMS publications since Oct 12, 2016.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 5-160 MG?
Since Oct 12, 2016, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has ranged from a low of $0.3449 (Jul 17, 2024) to a high of $0.5411 (Jan 11, 2017), with a median of $0.4545 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN 5-160 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AMLODIPINE-VALSARTAN 5-160 MG, so no direct lower-cost alternative is listed.
Who manufactures AMLODIPINE-VALSARTAN 5-160 MG?
AMLODIPINE-VALSARTAN 5-160 MG (NDC 65862073730) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification